Mounjaro®
Starting from £179.99/mo
Start journey Learn moreClinical trials in tens of thousands of adults have shown that semaglutide works best when a few practical habits sit alongside the injection itself. Getting the timing right, eating in a way that reduces nausea, and knowing what to watch for can meaningfully affect how you feel week to week on Wegovy. These are prescription-only medicines, so your prescriber will shape the details for your situation — but the evidence-backed principles below apply broadly and are worth knowing before your first pen arrives. The full Wegovy overview covers how the medicine is licensed and what to expect from the programme; this page focuses on the day-to-day practicalities once you've started.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, randomised nearly 2,000 adults with obesity to semaglutide 2.4mg or placebo over 68 weeks, alongside a structured lifestyle programme. Participants in the active group achieved an average body-weight reduction of around 15%. That lifestyle component wasn't decorative. The trial protocol included regular dietary counselling and physical activity guidance, and the results reflected that combination. The medicine reduces appetite and slows how quickly your stomach empties; what you do in the space that creates shapes the outcome.
The practical implication is straightforward. Wegovy creates a window (reduced hunger, earlier fullness) and how you use that window determines a lot. Eating smaller portions of protein-rich food tends to reduce nausea and preserve muscle mass. Drinking water steadily through the day rather than large amounts at meals helps too. These aren't instructions from us; they're patterns the trial evidence and NHS guidance consistently point toward, and your prescriber can discuss what fits your own circumstances, so it's also worth reading our tips for taking Wegovy to see how those patterns translate into everyday habits. You can read the broader semaglutide treatment information for context on how the medicine works at a pharmacological level.
One thing worth knowing early: the 0.25mg starting dose is there to let your system adjust, not to produce weight loss. The titration schedule exists for a reason — pushing through it faster doesn't improve outcomes and tends to worsen nausea.
A question our prescribers hear most weeks is some version of: "the nausea is bad, should I stop?" The honest answer is usually no, not yet. Nausea, loose stools, constipation, indigestion and fatigue are the most commonly reported side effects with semaglutide, and the NHS medicines guidance for semaglutide notes they are typically most pronounced after starting or stepping up a dose, often settling within days to a couple of weeks as your body adjusts.
A few practical habits make a real difference. Eating slowly and stopping when you feel full rather than finishing a plate tends to reduce post-meal nausea. Fatty, rich or very spicy foods are harder on the GI tract when you're on this medicine. Small, frequent meals (prioritising protein and vegetables over high-fat or high-sugar options) are better tolerated by most people in the early weeks, and our page covering what to do when taking Wegovy goes into more detail on building those habits day to day. Lying down straight after eating can make reflux worse, so a short walk or simply staying upright for thirty minutes helps.
If symptoms are genuinely unmanageable or persist beyond two weeks at a steady dose, that's a conversation for your prescriber. Severe, persistent stomach pain that spreads to the back is a different matter entirely, seek urgent medical attention. The MHRA has highlighted acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines, and sudden severe abdominal pain should never be waited out at home. Suspected side effects can be reported at yellowcard.mhra.gov.uk.
Wegovy comes as a pre-filled pen for subcutaneous injection into the abdomen, thigh or upper arm. Rotating your injection site each week matters more than most people realise, reusing the same small area repeatedly can cause skin changes that affect how the medicine is absorbed. Many people find the abdomen easiest for self-injection, particularly in the early weeks, and there's no clinical evidence that one recommended site produces better results than another.
Storage is simple but important. Keep your pens in the fridge between 2°C and 8°C. There is a limited window during which the pen can be kept at room temperature if needed for travel or convenience, but for the exact figures (which differ from those for tirzepatide) refer to the patient information leaflet in your pack rather than any online source, including this one. Temperature matters for the medicine's stability, and the leaflet is the definitive reference.
Inject on the same day each week where possible. If you need to shift the day by a day or two, your prescriber and the patient information leaflet will guide you on what's safe. Missing a dose or wondering whether to take it late is a question for your clinical team, not a forum. Our Wegovy tips page brings together a range of practical pointers on getting the most from your treatment, and the practical guide to taking Wegovy covers the administration steps in more detail.
For anyone thinking about the cost of ongoing treatment, our treatment page sets out what's included in the price at nume (consultation, prescription, delivery and aftercare together) so you can see the full picture before you start. On the cost side more broadly, the weight-loss treatment overview puts private and NHS routes in context.
Wegovy is titrated gradually, typically in four-weekly steps, up to a 2.4mg maintenance dose, and in some cases 7.2mg, following the MHRA's approval of a higher-dose option in early 2026. Each step up is another adjustment period, and the nausea and GI symptoms that settled on the previous dose may briefly return. Knowing this in advance tends to help: it isn't the medicine failing or your body rejecting it. It's the expected pattern, and it passes.
Longer-term, the things that matter most are consistency with the injection, maintaining the dietary habits that reduce side effects, and staying in contact with your clinical team when something changes. At nume, every repeat order is reviewed by a GPhC-registered prescriber (not processed automatically) so if your experience shifts at any dose, that's the right moment to raise it. Our clinical team and aftercare support are available seven days a week. If you have questions before starting, our FAQs cover a range of common concerns, and the contact page gets you to our team directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.